300244.SZ SHZ
Dian Diagnostics Group Co.,Ltd.
1W: -3.1%
1M: +11.2%
3M: +1.0%
YTD: -17.6%
1Y: +29.9%
3Y: -10.9%
5Y: -35.2%
¥20.52 ($3.06)
+0.33 (+1.63%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$15.8B
-12.0% ▼
5Y CAGR: +8.0%
Total Liabilities
$7.0B
-12.6% ▼
5Y CAGR: +4.6%
Shareholders Equity
$6.6B
-13.2% ▼
5Y CAGR: +10.5%
Cash & Investments
$2.2B
-34.7% ▼
5Y CAGR: +6.7%
Total Debt
$2.4B
-32.3% ▼
5Y CAGR: -6.6%
Net Debt
$571M
-0.9% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $1.7B | $2.2B | $4.2B | $3.0B | $1.8B |
| Short-Term Investments | $310M | $427M | $450M | $418M | $385M |
| Cash & ST Investments | $2.1B | $2.6B | $4.7B | $3.4B | $2.2B |
| Net Receivables | $4.6B | $6.6B | $10.1B | $8.5B | $7.5B |
| Inventory | $1.1B | $1.3B | $1.4B | $1.5B | $1.6B |
| Other Current Assets | $406M | $493M | $561M | $103M | $82M |
| Total Current Assets | $8.2B | $10.9B | $16.8B | $13.8B | $11.9B |
| Property, Plant & Equip. | $1.1B | $1.8B | $1.9B | $1.9B | $1.7B |
| Goodwill & Intangibles | $1.3B | $1.3B | $879M | $918M | $528M |
| Long-Term Investments | $977M | $583M | $634M | $670M | $575M |
| Other Non-Current Assets | $574M | $675M | $708M | $264M | $624M |
| Total Non-Current Assets | $4.2B | $4.7B | $4.3B | $4.1B | $3.9B |
| Total Assets | $12.4B | $15.6B | $21.1B | $17.9B | $15.8B |
| — Liabilities — | |||||
| Accounts Payable | $1.5B | $2.2B | $3.1B | $1.9B | $1.8B |
| Short-Term Debt | $2.4B | $2.5B | $1.9B | $931M | $616M |
| Deferred Revenue | $970M | $1.3B | $170M | $0 | $0 |
| Other Current Liabilities | $992M | -$386M | $2.6B | $2.0B | $1.3B |
| Total Current Liabilities | $5.6B | $6.6B | $7.7B | $4.9B | $4.7B |
| Long-Term Debt | $666M | $888M | $3.0B | $2.3B | $1.6B |
| Other Non-Current Liab. | -$461M | $195M | $490M | $499M | $544M |
| Total Non-Current Liabilities | $765M | $1.5B | $3.8B | $3.1B | $2.3B |
| Total Liabilities | $6.4B | $8.1B | $11.6B | $8.0B | $7.0B |
| — Equity — | |||||
| Common Stock | $620M | $620M | $627M | $627M | $625M |
| Retained Earnings | $2.4B | $3.5B | $4.8B | $4.8B | $4.0B |
| Accumulated OCI | $118M | $213M | $231M | $0 | $386M |
| Total Stockholders Equity | $4.7B | $5.8B | $7.4B | $7.6B | $6.6B |
| Total Liabilities & Equity | $12.4B | $15.6B | $21.1B | $17.9B | $15.8B |
| — Key Metrics — | |||||
| Total Debt | $3.8B | $4.4B | $6.0B | $3.6B | $2.4B |
| Net Debt | $2.0B | $2.2B | $1.8B | $577M | $571M |
| Total Investments | $1.3B | $1.0B | $1.1B | $1.1B | $960M |